Literature DB >> 23306300

To compare the results of knee evaluation after meniscus repair and anterior cruciate ligament reconstruction on the basis of Lysholm, HSS and IKDC scoring systems.

Grzegorz Kubiak1, Jarosław Fabiś.   

Abstract

BACKGROUND: Commonly used knee evaluation scoring systems differ according to their range of influence over the overall grade which is a composite of both subjective and objective category. Due to this fact the final outcomes obtained with individual scores may differ in relation to the evaluation of the same patient. The aim of the study was to compare the results obtained with the use of three most common knee evaluation scoring systems: Lysholm, HSS and IKDC. MATERIAL/
METHODS: We evaluated 27 knees in 26 patients following meniscus repair and anterior cruciate ligament reconstruction. The mean patient age was 25.7 years.
RESULTS: Result compatibility obtained for individual knees in all the three scoring systems was 41%. The highest, 70% compatibility rate concerned Lysholm and HSS scores, compatibility rate of the results between HSS and IKDC was less significant amounting to 56%, the lowest compatibility rate-24%--was noted between Lysholm and IKDC scores. In 7% of the evaluated knees the results were different for each scoring system incorporated.
CONCLUSIONS: On the basis of the analysis of knee evaluation results after meniscus repair and anterior cruciate ligament reconstruction the lack of total result compatibility between Lysholm, HSS and IKDC scores was noted.

Entities:  

Mesh:

Year:  2012        PMID: 23306300

Source DB:  PubMed          Journal:  Pol Orthop Traumatol        ISSN: 0009-479X


  1 in total

1.  Outcomes Following Arthroscopic Single and Double Bundle Anterior Cruciate Ligament (ACL) Reconstruction Supported by the Comprehensive Early Rehabilitation Program (CERP).

Authors:  Rafał Trąbka; Tomasz Maicki; Paweł Kamiński; Agata Pawełczyk; Paweł Zieliński; Magdalena Wilk-Frańczuk
Journal:  Med Sci Monit       Date:  2020-05-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.